Gong Yang
Faculty Member
Last active: 4/27/2017

Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma.

Yang G, Shu XO, Ruan ZX, Cai QY, Jin F, Gao YT, Zheng W
Cancer. 2005 103 (1): 52-8

PMID: 15565566 · DOI:10.1002/cncr.20729

BACKGROUND - It has been suggested that genetic polymorphisms in certain glutathione-S-transferase (GST) genes reduce the effectiveness of detoxifying cytotoxins generated by chemotherapeutic agents, potentially resulting in enhanced clinical responses to chemotherapy.

METHODS - The authors evaluated common polymorphisms in the GSTM1, GSTT1, and GSTP1 genes for associations with overall survival in 1034 patients with invasive breast carcinoma who were recruited into the Shanghai Breast Cancer Study between 1996 and 1998, treated with chemotherapy, and followed for a median of 5.3 years.

RESULTS - After adjusting for age, tumor stage, and the use of radiotherapy and tamoxifen, women who were homozygous for the variant GSTP1 105Val allele had a 60% reduction in mortality risk compared with women who were homozygous for the Ile allele (hazard ratio, 0.4; 95% confidence interval, 0.2-0.8). No association was found with respect to any of the GSTM1 or GSTT1 genotypes.

CONCLUSIONS - The results of the current study indicate a potential role for GSTP1 polymorphism in predicting the clinical outcomes of patients with breast carcinoma who are treated with chemotherapy.

MeSH Terms (16)

Acyltransferases Adult Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Carcinoma Case-Control Studies Female Genotype Glutathione Transferase Humans Middle Aged Neoplasm Invasiveness Polymorphism, Genetic Risk Factors Survival Analysis Treatment Outcome

Connections (3)

This publication is referenced by other Labnodes entities: